ADDED
The aggregate market value of the shares of Common Stock held by non-affiliates of the registrant on June 30, 2025 (based on the closing price for the Common Stock on the New York Stock Exchange as of the last business day of the registrant s most recently completed second fiscal quarter, June 30, 2025) was approximately $ 24.2 billion.
Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties.
Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, inflation, the conflict in Ukraine and continuing instability in the Middle East.
Our business is geographically diversified, with net sales in 2025 derived 42% from North and South America, 29% from Europe, and 29% from Asia and other countries.
The laboratory instruments and related service business accounted for approximately 56% of our net sales in 2025 and 2024, compared to 55% in 2023.
The industrial instruments and related service business accounted for approximately 39% of our net sales in 2025, 2024 and 2023.
The retail business accounted for approximately 5% of our net sales in 2025 and 2024, compared to 6% in 2023.
Service (representing service contracts, on-demand services, and replacement parts) accounted for approximately 25% of our net sales in 2025, 24% in 2024, and 23% in 2023.
Over the last three years, we have invested $574 million in research and development ($199 million in 2025, $189 million in 2024, and $185 million in 2023), which is approximately 5% of net sales for each year.
Employees Our total global workforce was approximately 18,100, consisting of 16,600 employees and 1,500 temporary personnel, as of December 31, 2025, and includes approximately 6,200 in Europe, 5,200 in North and South America, and 6,700 in Asia and other countries.
REMOVED
The aggregate market value of the shares of Common Stock held by non-affiliates of the registrant on June 28, 2024 (based on the closing price for the Common Stock on the New York Stock Exchange as of the last business day of the registrant s most recently completed second fiscal quarter, June 28, 2024) was approximately $ 29.7 billion.
Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties, including statements about expected revenue growth, inflation, ongoing developments related to Ukraine, and the conflict in the Middle East.
Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including inflation, ongoing developments related to Ukraine, and the conflict in the Middle East.
Our business is geographically diversified, with net sales in 2024 derived 42% from North and South America, 28% from Europe, and 30% from Asia and other countries.
The laboratory instruments and related service business accounted for approximately 56% of our net sales in 2024, 55% in 2023, and 57% in 2022.
The industrial instruments and related service business accounted for approximately 39% of our net sales in 2024 and 2023 and 38% in 2022.
The retail business accounted for approximately 5% of our net sales in 2024, 6% in 2023, and 5% in 2022.
Service (representing service contracts, on-demand services, and replacement parts) accounted for approximately 24% of our net sales in 2024, 23% in 2023, and 20% in 2022.
Over the last three years, we have invested $551 million in research and development ($189 million in 2024, $185 million in 2023, and $177 million in 2022), which is approximately 5% of net sales for each year.
Employees Our total global workforce was approximately 17,300, consisting of 16,000 employees and 1,300 temporary personnel, as of December 31, 2024, and includes approximately 6,200 in Europe, 4,800 in North and South America, and 6,300 in Asia and other countries.